Galcanezumab
Definition: Galcanezumab, sold under the brand name Emgality, is a humanized monoclonal antibody used for the prevention of migraine. It is also used for the treatment of cluster headaches. A substance called calcitonin gene-related peptide (CGRP) has been shown to be involved in the development of migraine by widening blood vessels in the brain. source: Wikipedia
- ID
- 782371005
- ID date
- 7 Sep 2021
- Previous ID
- 36787011000001102
- Name
- Galcanezumab